Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange.
作者信息
Rizzo Claudia, Rizzo Sergio, Scirè Elisabetta, Di Bona Danilo, Ingrassia Carlo, Franco Giovanni, Bono Roberto, Quintini Gerlando, Caruso Calogero
机构信息
Unit of Immunohaematology and Transfusion Medicine, Paolo Giaccone University Hospital, Department of Biopathology and Medical and Forensic Biotechnologies, University of Palermo, Palermo, Italy.
出版信息
Blood Transfus. 2012 Oct;10(4):521-32. doi: 10.2450/2012.0122-11. Epub 2012 Jun 27.
Abstract
摘要
相似文献
1
Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange.血栓性血小板减少性紫癜：基于我们血浆置换经验的文献综述
Blood Transfus. 2012 Oct;10(4):521-32. doi: 10.2450/2012.0122-11. Epub 2012 Jun 27.
2
Treatment of thrombotic thrombocytopenic purpura with the cryosupernatant fraction of plasma: a case report and review of the literature.用血浆冷上清组分治疗血栓性血小板减少性紫癜：一例报告及文献复习
Am J Med Sci. 1999 Sep;318(3):190-3. doi: 10.1097/00000441-199909000-00015.
3
Successful management of thrombotic thrombocytopenic purpura in a Jehovah's Witness without plasma exchange.在一名耶和华见证会成员中成功管理血栓性血小板减少性紫癜且未进行血浆置换
J Clin Apher. 2015 Feb;30(1):46-9. doi: 10.1002/jca.21325. Epub 2014 Apr 30.
4
Types of plasma exchange solution in the new scenario of thrombotic thrombocytopenic purpura treatment.血栓性血小板减少性紫癜治疗新场景下的血浆置换溶液类型。
Blood Transfus. 2024 May;22(3):275-276. doi: 10.2450/BloodTransfus.744. Epub 2024 Mar 4.
5
Treatment of plasmapheresis refractory thrombotic thrombocytopenic purpura with double-filtration membrane plasmapheresis.采用双重滤过膜血浆置换术治疗血浆置换难治性血栓性血小板减少性紫癜。
Transfus Apher Sci. 2013 Jun;48(3):313-4. doi: 10.1016/j.transci.2013.04.006. Epub 2013 Apr 28.
6
Postoperative thrombotic thrombocytopenic purpura in an infant: case report and literature review.婴儿术后血栓性血小板减少性紫癜：病例报告及文献复习。
J Pediatr Surg. 2011 Apr;46(4):764-766. doi: 10.1016/j.jpedsurg.2011.01.009.
7
Treating thrombotic thrombocytopenic purpura without plasma exchange during the COVID-19 pandemic. A case report and a brief literature review.COVID-19 大流行期间不进行血浆置换治疗血栓性血小板减少性紫癜。病例报告及文献复习。
Transfus Apher Sci. 2021 Jun;60(3):103107. doi: 10.1016/j.transci.2021.103107. Epub 2021 Feb 27.
8
The experience of treating patients with thrombotic thrombocytopenic purpura with solvent detergent plasma.使用溶剂去污血浆治疗血栓性血小板减少性紫癜患者的经验。
Br J Haematol. 2006 Apr;133(1):107; author reply 108. doi: 10.1111/j.1365-2141.2006.06008.x.
9
Thrombotic thrombocytopenic purpura: optimal management of plasma exchange, platelets and infection prevention.血栓性血小板减少性紫癜：血浆置换、血小板及感染预防的最佳管理
Blood Transfus. 2024 May;22(3):273-274. doi: 10.2450/BloodTransfus.710. Epub 2024 Mar 4.
10
Persistent increased troponin T in patient with thrombotic thrombocytopenic purpura responsive to treatment.血栓性血小板减少性紫癜患者经治疗后肌钙蛋白T持续升高。
Clin Chim Acta. 2010 Jun 3;411(11-12):890-1. doi: 10.1016/j.cca.2010.03.006. Epub 2010 Mar 11.
引用本文的文献
1
Immune thrombotic thrombocytopenic purpura: Spotlight on long-term outcomes and survivorship.免疫性血栓性血小板减少性紫癜：聚焦长期结局与生存情况。
Front Med (Lausanne). 2023 Feb 28;10:1137019. doi: 10.3389/fmed.2023.1137019. eCollection 2023.
2
Von Willebrand factor in diagnostics and treatment of cardiovascular disease: Recent advances and prospects.血管性血友病因子在心血管疾病诊断与治疗中的应用：最新进展与展望
Front Cardiovasc Med. 2022 Dec 2;9:1038030. doi: 10.3389/fcvm.2022.1038030. eCollection 2022.
3
The Challenges in Diagnosis and Management of Acquired Thrombotic Thrombocytopenic Purpura: Consensus Report from Three Gulf Countries.获得性血栓性血小板减少性紫癜的诊断与管理挑战：来自三个海湾国家的共识报告
Oman Med J. 2022 Jul 31;37(4):e407. doi: 10.5001/omj.2022.32. eCollection 2022 Jul.
4
Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology.切应力诱导的血管性血友病因子激活与心血管病理学。
Int J Mol Sci. 2020 Oct 21;21(20):7804. doi: 10.3390/ijms21207804.
5
Successful treatment of plasma exchange-refractory thrombotic thrombocytopenic purpura with rituximab: A case report.利妥昔单抗成功治疗血浆置换难治性血栓性血小板减少性紫癜：一例报告。
World J Clin Cases. 2020 Jun 26;8(12):2617-2622. doi: 10.12998/wjcc.v8.i12.2617.
6
Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura.卡泊西单抗作为获得性血栓性血小板减少性紫癜的一种新兴治疗选择。
Drug Des Devel Ther. 2019 Apr 17;13:1251-1258. doi: 10.2147/DDDT.S134470. eCollection 2019.
7
Changes in plasma von Willebrand factor and von Willebrand factor cleaving protease in thrombotic thrombocytopenic purpura: A case report.血栓性血小板减少性紫癜患者血浆血管性血友病因子及血管性血友病因子裂解蛋白酶的变化：病例报告
Exp Ther Med. 2018 Jan;15(1):205-209. doi: 10.3892/etm.2017.5361. Epub 2017 Oct 24.
8
Does corticosteroid treatment cause prolonged recovery and increased total bilirubin level in severe ADAMTS-13-deficient TTP patient?
Wien Klin Wochenschr. 2015 Oct;127(19-20):795-8. doi: 10.1007/s00508-014-0691-5. Epub 2015 Jan 10.
9
Haemostasis and immunity: cross-talking systems?止血与免疫：相互作用的系统？
Blood Transfus. 2014 Jan;12 Suppl 1(Suppl 1):s348-9. doi: 10.2450/2013.0301-12. Epub 2013 May 17.
本文引用的文献
1
Thrombotic microangiopathy in haematopoietic cell transplantation: an update.造血细胞移植中的血栓性微血管病：最新进展。
Mediterr J Hematol Infect Dis. 2010;2(3):e2010033. doi: 10.4084/MJHID.2010.033. Epub 2010 Nov 3.
2
The modulation of platelet adhesion and activation by chitosan through plasma and extracellular matrix proteins.壳聚糖通过血浆和细胞外基质蛋白对血小板黏附和激活的调节。
Biomaterials. 2011 Oct;32(28):6655-62. doi: 10.1016/j.biomaterials.2011.05.062. Epub 2011 Jun 14.
3
Rituximab therapy for autoimmune haematological diseases.利妥昔单抗治疗自身免疫性血液系统疾病。
Eur J Intern Med. 2011 Jun;22(3):220-9. doi: 10.1016/j.ejim.2010.12.016. Epub 2011 Jan 31.
4
Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency.血型 O 和黑种人是与严重 ADAMTS13 缺乏相关的血栓性血小板减少性紫癜的独立危险因素。
Transfusion. 2011 Oct;51(10):2237-43. doi: 10.1111/j.1537-2995.2011.03125.x. Epub 2011 Apr 6.
5
Succinate independently stimulates full platelet activation via cAMP and phosphoinositide 3-kinase-β signaling.琥珀酸通过 cAMP 和磷酯酰肌醇 3-激酶-β信号通路独立地刺激完全血小板活化。
J Thromb Haemost. 2011 Feb;9(2):361-72. doi: 10.1111/j.1538-7836.2010.04158.x.
6
An inquiry into the relationship between ABO blood group and thrombotic thrombocytopenic purpura.探讨 ABO 血型与血栓性血小板减少性紫癜的关系。
Vox Sang. 2009 May;96(4):344-8. doi: 10.1111/j.1423-0410.2009.01164.x.
7
Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.临床实践中治疗性血液成分单采的使用指南——来自美国血液成分单采协会血液成分单采应用委员会的循证方法
J Clin Apher. 2010;25(3):83-177. doi: 10.1002/jca.20240.
8
Pregnancy-associated thrombotic thrombocytopenic purpura with anti-centromere antibody-positive Raynaud's syndrome.
Intern Med. 2010;49(12):1229-32. doi: 10.2169/internalmedicine.49.3465. Epub 2010 Jun 15.
9
Survival and relapse in patients with thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜患者的生存和复发。
Blood. 2010 Feb 25;115(8):1500-11; quiz 1662. doi: 10.1182/blood-2009-09-243790. Epub 2009 Dec 23.
10
IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura.获得性血栓性血小板减少性紫癜患者抗 ADAMTS13 抗体的 IgG 亚类分布。
J Thromb Haemost. 2009 Oct;7(10):1703-10. doi: 10.1111/j.1538-7836.2009.03568.x. Epub 2009 Aug 11.
Zotero 插件